Modern Dose Escalation Phase 1 Trials with East® ESCALATE Published 2014-07-10 Download video MP4 360p Download video MP4 720p Recommendations 56:21 Practical Model-based Approaches for Phase 1 Oncology Trials 54:13 Group Sequential Designs and Sample Size Re-estimation - Modern Uses 1:28:14 Phase 1 Dose Escalation: Introduction to Adaptive Trial Designs using FACTS 35:32 Bayesian-Based Dose Escalation Clinical Trial Designs - Pantelis Vlachos, Cytel 1:00:50 Design of Adaptive Phase 1 Clinical Trials for Dose Escalation using the DEDUCE Application 39:35 Bayesian Optimal Interval Design Fundamentals 05:28 Clinical Trials: A Principal Investigator Explains Dose Escalation, Phase by Phase. 04:41 What Makes Oncology Clinical Trials Unique From Others? - A Clinical Research Site Perspective 1:01:10 Webinar: Phase I trials in oncology: Pros and cons of current designs 06:59 Understanding Clinical Trials 59:30 Study Designs for Oncology and Rare Diseases 1:00:51 Head-to-Head Comparisons using Real-World Data 05:23 Accelerating Clinical Trials with AI: The Future of AI and Health | Michael Lingzhi Li | TEDxBoston 23:00 Model-based Designs in Oncology Dose-finding Studies 1:04:37 Synthetic Controls In Clinical Trials 57:09 Introduction to BOIN: The Effective, Flexible and Transparent Phase I Clinical Trial Design 34:21 Phase I Clinical Trials: Objectives, Design, and Endpoints 50:22 Introduction to Population Enrichment Trial Designs 31:53 Charles Green: Bayesian Adaptive Trial Designs 30:48 Designing Proof-of-Concept Clinical Trials - Ashwin Gollerkeri, M.D., Pfizer Similar videos 43:29 Phase 1 Dose Escalation Trials with ESCALATE 04:37 Design_3_Plus_3 02:07 Design_Accl_Titration 01:17 [53] Flexible Bayesian methods for cancer phase I trials. Dose escalation with overdose control 20:23 Phase I Clinical Trials Overview | Dana-Farber Cancer Institute 04:46 Phase 1a 1b Phase 2a 2b Clinical Trial Differences 1:27:26 Detangle modern dose-finding designs: A tutorial 02:00 [54] Cancer phase I clinical trials: efficient dose escalation with overdose control 32:33 A Model-Free Approach for a Combination Phase 1 Trial - Adrian Mander, MRC 22:00 Dose Escalation Design with Consideration of Late Onset Toxicity 03:04 Phase 1a 1b and 2a 2b clinical trials simple explanation in 3 min 55:14 Designs of dose escalation studies in phase I oncology trials 30:50 A Bayesian Industry Approach to Phase 1 Combination Trials in Oncology - Satrajit Roychoudhury More results